- Home
- INSM vs IT Comparison
INSM vs IT Comparison
Compare INSM & IT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSM
- IT
- Stock Information
- Founded
- INSM 1988
- IT 1979
- Country
- INSM United States
- IT United States
- Employees
- INSM N/A
- IT N/A
- Industry
- INSM Biotechnology: Pharmaceutical Preparations
- IT Other Consumer Services
- Sector
- INSM Health Care
- IT Consumer Discretionary
- Exchange
- INSM Nasdaq
- IT Nasdaq
- Market Cap
- INSM 26.0B
- IT 30.7B
- IPO Year
- INSM 2000
- IT 1993
- Fundamental
- Price
- INSM $145.86
- IT $252.92
- Analyst Decision
- INSM Strong Buy
- IT Hold
- Analyst Count
- INSM 18
- IT 9
- Target Price
- INSM $146.81
- IT $335.75
- AVG Volume (30 Days)
- INSM 2.0M
- IT 1.4M
- Earning Date
- INSM 10-30-2025
- IT 11-04-2025
- Dividend Yield
- INSM N/A
- IT N/A
- EPS Growth
- INSM N/A
- IT 54.75
- EPS
- INSM N/A
- IT 16.25
- Revenue
- INSM $398,105,000.00
- IT $6,420,009,000.00
- Revenue This Year
- INSM $31.95
- IT $6.60
- Revenue Next Year
- INSM $125.46
- IT $4.21
- P/E Ratio
- INSM N/A
- IT $15.58
- Revenue Growth
- INSM 21.15
- IT 5.89
- 52 Week Low
- INSM $60.40
- IT $223.65
- 52 Week High
- INSM $149.08
- IT $584.01
- Technical
- Relative Strength Index (RSI)
- INSM 72.40
- IT 46.95
- Support Level
- INSM $138.73
- IT $244.99
- Resistance Level
- INSM $148.22
- IT $253.30
- Average True Range (ATR)
- INSM 3.85
- IT 7.02
- MACD
- INSM -0.97
- IT 4.63
- Stochastic Oscillator
- INSM 78.08
- IT 82.53
About INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
About IT Gartner Inc.
Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.